secwatch.observer — SEC 8-K summary
======================================

Issuer:     Immunome Inc. (IMNM)
CIK:        0001472012
Form:       8-K
Filed at:   2024-01-02T23:59:59+00:00
Accession:  0001104659-24-000121
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Immunome appoints Carol Schafer as director, Audit Committee Chair
------------------------------------------------------------------

- Carol Schafer appointed Class I director, Chair of Audit Committee, and member of Nominating Committee, effective Jan 2, 2024.
- Annual retainers: $40,000 for board, $15,000 for Audit Chair, $5,000 for Nominating Committee; plus option grant worth $270,000.
- James Boylan and Jean-Jacques Bienaimé stepped down from Audit and Nominating Committees, respectively.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1472012/000110465924000121/0001104659-24-000121-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1472012/000110465924000121/tm2334002d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-000121

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer